ADD CONDITION
Acetaminophen
Last content change checked dailysee data sync status
- Active ingredient
- Acetaminophen 0.5 g/1 g – 1000 mg
- Reference brand
- Tylenol Extra Strength
- Dosage forms
- Bar, Chewable
- Capsule
- Capsule, Coated
- Capsule, Gelatin Coated
- Capsule, Liquid Filled
- Chewable Gel
- Elixir
- Granule, for Solution
- Liquid
- Powder
- Solution
- Solution/ Drops
- Strip
- Suppository
- Suspension
- Suspension/ Drops
- Syrup
- Tablet
- Tablet, Chewable
- Tablet, Coated
- Tablet, Delayed Release
- Tablet, Effervescent
- Tablet, Extended Release
- Tablet, Film Coated
- Tablet, Film Coated, Extended Release
- Tablet, Orally Disintegrating
- Routes
- Oral
- Rectal
- Prescription status
- OTC (over the counter)
- Marketed in the U.S.
- Since 1984
- Label revision date
- March 23, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Active ingredient
- Acetaminophen 0.5 g/1 g – 1000 mg
- Reference brand
- Tylenol Extra Strength
- Dosage forms
- Bar, Chewable
- Capsule
- Capsule, Coated
- Capsule, Gelatin Coated
- Capsule, Liquid Filled
- Chewable Gel
- Elixir
- Granule, for Solution
- Liquid
- Powder
- Solution
- Solution/ Drops
- Strip
- Suppository
- Suspension
- Suspension/ Drops
- Syrup
- Tablet
- Tablet, Chewable
- Tablet, Coated
- Tablet, Delayed Release
- Tablet, Effervescent
- Tablet, Extended Release
- Tablet, Film Coated
- Tablet, Film Coated, Extended Release
- Tablet, Orally Disintegrating
- Routes
- Oral
- Rectal
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1984
- Label revision date
- March 23, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Acetaminophen is a widely used pain reliever and fever reducer. It is effective in temporarily alleviating minor aches and pains associated with various conditions, including headaches, toothaches, muscular aches, backaches, minor arthritis pain, and symptoms of the common cold. Additionally, acetaminophen is known to help reduce fever.
Available in various forms such as tablets, capsules, and liquid suspensions, acetaminophen is suitable for both adults and children. It is important to note that acetaminophen does not contain aspirin, making it a safer option for individuals who may be sensitive to aspirin or for children. Always follow dosing instructions and consult with a healthcare provider if you have any questions or concerns about its use.
Uses
You can use this medication to temporarily relieve minor aches and pains caused by various conditions, including headaches, toothaches, backaches, muscular aches, and minor arthritis pain. It is also effective for alleviating discomfort associated with menstrual cramps and the common cold or flu. Additionally, this medication helps to reduce fever.
Whether you're dealing with everyday aches or discomfort from specific conditions, this medication can provide relief when you need it most. Always follow the recommended dosage instructions for safe and effective use.
Dosage and Administration
For adults and children aged 12 years and older, take 2 caplets or tablets every 6 hours while symptoms last. Do not exceed 6 caplets or tablets in a 24-hour period, unless directed by a doctor. You should not use this medication for more than 10 days unless advised by a healthcare professional.
For children under 12 years, it is important to consult a doctor for appropriate dosing instructions. If you are using a liquid form for children, shake well before use and measure the dose using the provided dosing cup or syringe. Repeat the dose every 4 hours as needed, but do not exceed 5 doses in a 24-hour period. Always refer to the specific dosing chart based on the child's weight or age for accurate dosing.
What to Avoid
You should avoid using acetaminophen if you are allergic to it or any of its inactive ingredients. Additionally, do not take it with any other medications that contain acetaminophen, whether prescription or nonprescription. If you are unsure whether a drug contains acetaminophen, consult a doctor or pharmacist.
For children, do not use acetaminophen if they have ever had an allergic reaction to it or its ingredients. Always adhere to the recommended dosage and avoid exceeding it, as doing so can lead to serious health risks, including liver damage. If you experience any adverse effects or if symptoms persist, seek medical advice promptly.
Side Effects
Taking acetaminophen can lead to severe liver damage, especially if you exceed 4,000 mg in 24 hours, take it with other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using it. For children, the maximum is typically five doses in 24 hours.
Be aware of potential severe skin reactions, which may include symptoms like skin reddening, blisters, or rash. If you experience any of these, stop using the product and seek medical help immediately.
You should stop using acetaminophen and consult a doctor if:
Pain worsens or lasts more than 10 days for adults, or more than 5 days for children.
Fever worsens or lasts more than 3 days.
New symptoms appear, or if there is redness or swelling, as these could indicate a serious condition.
Always consult a doctor before using acetaminophen if you have liver disease or are taking blood-thinning medications like warfarin. In case of overdose, seek medical help or contact a Poison Control Center immediately, as prompt attention is crucial.
Warnings and Precautions
This product contains acetaminophen, which can cause severe liver damage if you take more than 4,000 mg in 24 hours, take it with other medications containing acetaminophen, or consume 3 or more alcoholic drinks daily while using it. For children, the maximum daily dose is 5 doses in 24 hours.
Be aware of severe skin reactions, which may include skin reddening, blisters, or rash. If you experience any of these symptoms, stop using the product and seek medical help immediately.
Before using this product, consult a doctor if you have liver disease or are taking the blood-thinning medication warfarin.
Stop using and call your doctor if:
Pain worsens or lasts more than 10 days for adults (or more than 5 days for children).
Fever worsens or lasts more than 3 days.
New symptoms occur.
Redness or swelling is present, as these could indicate a serious condition.
In case of overdose, seek emergency medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is crucial for both adults and children, even if no symptoms are noticeable.
Overdose
In case of an overdose of acetaminophen or any pain reliever, it is crucial to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222. Quick medical attention is essential for both adults and children, even if you do not notice any signs or symptoms.
Taking more than the recommended dose can lead to severe liver damage. For adults, this can occur if you take more than 4,000 mg in 24 hours, while for children, it can happen if they take more than 5 doses in the same timeframe. Additionally, combining acetaminophen with other medications that contain acetaminophen or consuming three or more alcoholic drinks daily while using these products can increase the risk of liver damage.
Always follow the recommended dosage instructions and keep medications out of reach of children to prevent accidental ingestion. If you suspect an overdose, do not wait for symptoms to appear; act quickly to ensure safety.
Pregnancy Use
If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using any acetaminophen products. This includes various forms such as tablets, capsules, and liquid solutions. While acetaminophen is commonly used for pain relief and fever reduction, the safety of its use during pregnancy has not been fully established, and potential risks to the fetus are not clearly defined.
Always seek medical advice to ensure that the benefits of using acetaminophen outweigh any potential risks. This precaution applies to all acetaminophen-containing products, regardless of their specific formulation or brand.
Lactation Use
If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using any medication, including acetaminophen. Many products indicate that there is a potential for acetaminophen to be excreted in breast milk, which means it can pass into your breast milk and potentially affect your infant.
While some products do not provide specific warnings or recommendations for nursing mothers, caution is advised when administering these medications. The effects of acetaminophen on nursing infants are not well studied, so monitoring your infant for any adverse effects is recommended if you choose to take this medication while breastfeeding. Always prioritize discussing your options with your healthcare provider to ensure the safety of both you and your baby.
Pediatric Use
For children under 12 years, it is important to consult a doctor before using any acetaminophen products. For children aged 12 years and older, the typical dosage is 2 caplets every 6 hours while symptoms last, with a maximum of 6 caplets in 24 hours, unless directed otherwise by a doctor. Do not use for more than 10 days without medical advice.
When using liquid formulations for children aged 2 to 11 years, dosing should be based on weight if possible. For example, children weighing 24-35 lbs (2-3 years) should receive 5 mL, while those weighing 72-95 lbs (11 years) can take 15 mL. No more than 5 doses should be given in 24 hours, and if symptoms persist or worsen, consult a doctor. Always keep medications out of reach of children and seek immediate medical help in case of overdose, even if no symptoms are present.
Geriatric Use
When considering pain relief medications, it's important to be aware of specific guidelines for older adults. If you have liver disease, consult your doctor before using any acetaminophen products, as this can affect how your body processes the medication. Additionally, if you are taking blood thinners like warfarin, it's crucial to discuss this with your healthcare provider to avoid potential interactions.
For adults aged 12 and older, the general recommendation is not to exceed 6 caplets in 24 hours unless directed by a doctor, and to avoid using the medication for more than 10 days without medical advice. Be vigilant about the risk of overdose; seek immediate medical attention if you suspect an overdose, even if no symptoms are present. Always follow dosing instructions carefully and consult your healthcare provider for personalized advice, especially if you have underlying health conditions or are taking multiple medications.
Renal Impairment
When considering medications, it's important to be aware of how kidney health can affect their use. Many common pain relievers, particularly those containing acetaminophen, do not provide specific guidance regarding dosage adjustments or monitoring for individuals with kidney issues. However, if you have renal impairment, it is advisable to consult with your healthcare provider before using these medications.
For certain medications, such as Valumeds Extra Strength Pain Relief and Acetaminophen, dosage adjustments may be necessary, especially for patients with a creatinine clearance of less than 30 mL/min. Regular monitoring of renal function is recommended for those with kidney problems. Always discuss your health conditions with your doctor to ensure safe and effective use of any medication.
Hepatic Impairment
You should be aware that many pain relief products contain acetaminophen, which can lead to severe liver damage if not used correctly. To avoid this risk, do not exceed 4,000 mg of acetaminophen in a 24-hour period, and be cautious if you are taking other medications that also contain acetaminophen or if you consume three or more alcoholic drinks daily while using these products.
If you or your child have liver disease, it is essential to consult a doctor before using any acetaminophen-containing product. For children, the maximum daily dose is typically five doses in 24 hours, depending on the specific product. Always seek immediate medical help if you suspect an overdose, as prompt attention is crucial.
Drug Interactions
If you are taking the blood-thinning medication warfarin, it's crucial to consult with your doctor or pharmacist before using any acetaminophen products. Acetaminophen can increase the effects of warfarin, potentially leading to a higher risk of bleeding. This interaction may also affect your INR (International Normalized Ratio) levels, which are used to monitor blood clotting.
Additionally, avoid using multiple products containing acetaminophen simultaneously, as this can lead to severe liver damage. Always discuss your current medications and any health conditions, such as liver disease, with your healthcare provider to ensure safe use.
Storage and Handling
To ensure the effectiveness and safety of your pain reliever or acetaminophen products, store them at a controlled room temperature between 20°C to 25°C (68°F to 77°F). Some products may allow for excursions between 15°C to 30°C (59°F to 86°F). It's important to keep these medications away from high humidity and excessive heat, as these conditions can affect their quality. Always check the packaging for the expiration date and lot number.
When handling these products, do not use them if the packaging is damaged, such as if the neckband, foil seal, or carton is broken or missing. For liquid forms, ensure they are stored tightly closed and protected from light. After opening, some products may need to be discarded after a certain period, so refer to the specific instructions on the label. Always keep medications out of reach of children.
Uses and Indications
This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including:
Headache
Muscular aches
Backache
Minor pain of arthritis
Toothache
Premenstrual and menstrual cramps
The common cold
Flu
Sore throat
Additionally, this drug is indicated for the temporary reduction of fever.
Limitations of Use
No teratogenic or nonteratogenic effects have been mentioned for this drug.
Dosage and Administration
Adults and children 12 years and older are advised to take 2 caplets or tablets every 6 hours while symptoms persist. The maximum dosage should not exceed 6 caplets or tablets in a 24-hour period unless directed by a healthcare professional. This medication should not be used for more than 10 days unless otherwise directed by a doctor.
For adults and children 12 years and older who require extended-release formulations, the recommended dosage is 2 caplets every 8 hours with water. These caplets must be swallowed whole and should not be crushed, chewed, split, or dissolved. The maximum dosage remains at 6 caplets in a 24-hour period, and the same duration of use applies.
Children under 12 years should not use this medication without consulting a doctor. For children under 2 years, it is essential to seek medical advice before administration.
For liquid formulations intended for children, the dosage should be determined based on weight or age, as outlined in the provided dosing chart. The recommended frequency for these doses is every 4 hours while symptoms last, with a maximum of 5 doses in a 24-hour period. It is crucial to shake the suspension well before use and to utilize only the enclosed dosing device designed for the product.
In all cases, patients should be advised to adhere strictly to the recommended dosages to avoid the risk of overdose, which can lead to serious health complications.
Contraindications
Do not use in patients who are allergic to acetaminophen or any of the inactive ingredients in this product. Use is contraindicated with any other drug containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a doctor or pharmacist is advised.
In pediatric patients, do not use if the child has ever had an allergic reaction to this product or any of its ingredients. Additionally, for children, it is important to adhere to recommended dosages and not exceed them, as overdose may lead to serious health risks.
Warnings and Precautions
Liver Warning This product contains acetaminophen. Severe liver damage may occur if you take:
More than 4,000 mg of acetaminophen in 24 hours.
With other drugs containing acetaminophen.
3 or more alcoholic drinks every day while using this product.
For children, severe liver damage may occur if they take more than 5 doses in 24 hours, which is the maximum daily amount.
Allergy Alert Acetaminophen may cause severe skin reactions. Symptoms may include:
Skin reddening
Blisters
Rash If a skin reaction occurs, stop use and seek medical help right away.
Sore Throat Warning If sore throat is severe, persists for more than 2 days, or is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
General Precautions
Ask a doctor before use if you have liver disease.
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin.
Do not use with any other drug containing acetaminophen (prescription or nonprescription). If unsure whether a drug contains acetaminophen, ask a doctor or pharmacist.
Get Emergency Medical Help In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children, even if you do not notice any signs or symptoms.
Stop Taking and Call Your Doctor Stop use and ask a doctor if:
Pain gets worse or lasts more than 10 days in adults or more than 5 days in children.
Fever gets worse or lasts more than 3 days.
New symptoms occur.
Redness or swelling is present. These could be signs of a serious condition.
Side Effects
Severe liver damage may occur if acetaminophen is taken in excess of 4,000 mg in 24 hours, with other drugs containing acetaminophen, or if three or more alcoholic drinks are consumed daily while using this product.
Allergy Alert
Acetaminophen may cause severe skin reactions. Symptoms may include:
Skin reddening
Blisters
Rash
If a skin reaction occurs, patients should stop use and seek medical help immediately.
Serious Adverse Reactions
Patients should stop use and consult a doctor if:
Pain worsens or lasts more than 10 days (adults) or 5 days (children).
Fever worsens or lasts more than 3 days.
New symptoms occur.
Redness or swelling is present, as these could indicate a serious condition.
Overdose Warning
In case of overdose, patients should seek medical help or contact a Poison Control Center immediately (1-800-222-1222). Quick medical attention is critical for both adults and children, even if no signs or symptoms are noticed.
Special Considerations
Patients with liver disease should consult a doctor before use.
Patients taking blood-thinning medications, such as warfarin, should consult a doctor or pharmacist before use.
Pediatric Considerations
For children, severe liver damage may occur if more than 5 doses are taken in 24 hours, or if taken with other drugs containing acetaminophen. If sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a doctor should be consulted promptly.
Summary of Adverse Reactions
Liver Damage: Risk increases with high doses, concurrent use of other acetaminophen-containing products, and alcohol consumption.
Skin Reactions: Potential for severe reactions requiring immediate medical attention.
Symptoms Indicating Serious Conditions: Include prolonged pain or fever, new symptoms, and signs of redness or swelling.
Patients are advised to adhere strictly to dosing guidelines and to consult healthcare professionals with any concerns regarding the use of acetaminophen.
Drug Interactions
Taking acetaminophen in conjunction with the blood-thinning medication warfarin may significantly increase the risk of bleeding. It is essential for patients to consult a healthcare professional before using acetaminophen if they are currently on warfarin therapy. The following points summarize the interactions and recommendations regarding acetaminophen and warfarin:
Pharmacodynamic Interactions
Acetaminophen may enhance the anticoagulant effect of warfarin, leading to an increased risk of bleeding. Patients should monitor their International Normalized Ratio (INR) closely if these medications are used together.
The risk of bleeding may be particularly pronounced in patients consuming alcohol or taking other medications that affect liver function.
Recommendations
Patients should be advised to avoid using any other medications containing acetaminophen, whether prescription or nonprescription, while taking acetaminophen. If there is uncertainty about whether a medication contains acetaminophen, consultation with a healthcare provider is recommended.
Individuals with liver disease should seek medical advice before using acetaminophen, as it may exacerbate liver-related issues.
Monitoring
Regular monitoring of INR levels is crucial for patients taking both acetaminophen and warfarin to ensure safe and effective anticoagulation therapy.
Specific Product Information
Many acetaminophen products, including various formulations and brands, carry warnings regarding their use with warfarin. Patients should be informed about these warnings and the importance of discussing their medication regimen with healthcare professionals.
In summary, the combination of acetaminophen and warfarin requires careful management and monitoring to mitigate the risk of serious adverse effects, particularly bleeding.
Pediatric Use
Pediatric patients under 12 years of age should not use this product without consulting a doctor. For children aged 12 years and older, the recommended dosage is typically 2 caplets every 6 hours while symptoms persist, not to exceed 6 caplets in 24 hours unless directed by a doctor. The maximum duration of use is generally limited to 10 days unless otherwise directed.
Dosage for Children Aged 2 to 11 Years
For children aged 2 to 11 years, dosing should be based on weight when possible. The following dosing chart provides guidance:
Under 24 lbs (Under 2 years): Ask a doctor.
24-35 lbs (2-3 years): 5 mL (1 tsp).
36-47 lbs (4-5 years): 7.5 mL (1.5 tsp).
48-59 lbs (6-8 years): 10 mL (2 tsp).
60-71 lbs (9-10 years): 12.5 mL (2.5 tsp).
72-95 lbs (11 years): 15 mL (3 tsp).
Dosing may be repeated every 4 hours while symptoms last, but should not exceed 5 doses in 24 hours.
Warnings
Liver Warning: Severe liver damage may occur if the child takes more than 5 doses in 24 hours or with other drugs containing acetaminophen.
Allergy Alert: Acetaminophen may cause severe skin reactions, including skin reddening, blisters, and rash. If a skin reaction occurs, stop use and seek medical help immediately.
Sore Throat Warning: If sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
Consultation
Consult a doctor before use if the child has liver disease or is taking the blood-thinning drug warfarin.
Overdose Warning
In case of overdose, get medical help or contact a Poison Control Center immediately. Quick medical attention is critical for both adults and children, even if no signs or symptoms are noticed.
Duration of Use
If pain lasts more than 5 days or fever lasts more than 3 days, stop use and consult a doctor.
Geriatric Use
Elderly patients may have an increased risk of adverse effects when using acetaminophen-containing products. It is advised that healthcare providers consult with elderly patients regarding their liver health, as many may have underlying liver conditions that could affect drug metabolism.
For adults and children aged 12 years and older, the maximum recommended dosage is typically 6 caplets in 24 hours, unless otherwise directed by a physician. Patients should not use these products for more than 10 days without medical advice.
In cases of overdose, prompt medical attention is critical, even if no symptoms are immediately apparent. There is no specific information provided regarding dosage adjustments or safety concerns for elderly patients in many product inserts; however, caution is warranted due to potential comorbidities and the possibility of increased sensitivity to side effects in this population.
Overall, while specific geriatric use data may be limited, healthcare providers should exercise caution and consider individual patient conditions when prescribing acetaminophen to elderly patients.
Pregnancy
Pregnant patients should consult a healthcare professional before using any acetaminophen-containing products, including various formulations such as tablets, capsules, and liquids. The safety of acetaminophen during pregnancy has not been firmly established, and potential risks to the fetus are not clearly defined.
While many product labels recommend seeking medical advice if pregnant or breastfeeding, specific contraindications, safety concerns, dosage modifications, or special precautions are often not detailed. It is advised that pregnant patients discuss the use of acetaminophen with their healthcare provider to weigh the potential benefits against risks, especially if they have underlying health conditions or are taking other medications.
In summary, caution is advised when considering the use of acetaminophen during pregnancy, and healthcare professionals should be consulted to ensure the safety of both the mother and the fetus.
Lactation
Nursing mothers should consult a healthcare professional before using acetaminophen products, as there is a potential for excretion in breast milk. Caution is advised due to the potential risk to breastfed infants, as the effects of acetaminophen on nursing infants are not well studied.
While some products do not provide specific warnings or recommendations regarding their use in nursing mothers, it is generally recommended to monitor infants for any adverse effects if the nursing mother takes this medication.
In summary, lactating mothers are advised to seek medical guidance prior to using acetaminophen, considering the potential for excretion in breast milk and the associated risks to their infants.
Renal Impairment
Patients with renal impairment may require careful consideration when using various acetaminophen formulations. While many product labels do not provide specific information regarding dosage adjustments or monitoring for patients with kidney problems, there are notable exceptions.
For certain formulations, it is indicated that renal impairment may necessitate dosage adjustments. Specifically, patients with a creatinine clearance of less than 30 mL/min should consider a reduced dose. Regular monitoring of renal function is recommended for these patients, and it is advisable to perform renal function tests prior to initiating therapy and periodically thereafter.
In general, the majority of acetaminophen products lack explicit guidance on renal impairment, dosage adjustments, or special monitoring requirements. Therefore, healthcare providers should exercise caution and consider individual patient circumstances when prescribing acetaminophen to patients with renal impairment.
Hepatic Impairment
Patients with hepatic impairment should exercise caution when using products containing acetaminophen. The following guidelines apply:
Dosage Adjustments: Dosage modifications may be necessary for patients with liver problems. The maximum daily dose for adults is generally limited to 4,000 mg of acetaminophen, while for children, it is typically capped at 5 doses in 24 hours, depending on the specific formulation.
Monitoring Requirements: Special monitoring of liver function tests is recommended for patients with hepatic impairment. Regular assessments can help identify any potential liver damage early.
Warnings: Severe liver damage may occur if patients exceed the recommended dosages, take acetaminophen with other products containing acetaminophen, or consume three or more alcoholic drinks daily while using these medications.
Consultation: Patients are advised to consult a healthcare professional before using acetaminophen if they have liver disease. This includes discussing any potential interactions with other medications and the appropriateness of acetaminophen for their specific condition.
Overdose Risks: Taking more than the recommended dose can lead to liver damage. In the event of an overdose, immediate medical attention is critical, even if no symptoms are present.
These precautions are essential to ensure the safe use of acetaminophen in patients with hepatic impairment.
Overdosage
In the event of an overdose, immediate medical assistance should be sought by contacting a Poison Control Center or a healthcare professional. The national Poison Control Center can be reached at 1-800-222-1222. Prompt medical attention is critical for both adults and children, even if no symptoms are initially observed.
Symptoms of overdose may include severe liver damage, which can occur if the maximum daily dosage is exceeded. For adults, taking more than 4,000 mg of acetaminophen in 24 hours is considered excessive. For children, severe liver damage may occur if more than 5 doses are taken within the same timeframe. Additionally, liver damage risks increase if acetaminophen is taken in conjunction with other medications containing acetaminophen or if an adult consumes three or more alcoholic drinks daily while using this product.
It is essential to adhere strictly to the recommended dosages to avoid the risk of overdose. If an overdose is suspected, individuals should not wait for symptoms to appear before seeking help, as the consequences can be severe and potentially life-threatening.
Nonclinical Toxicology
Teratogenic Effects
Acetaminophen has been associated with specific warnings regarding its use during pregnancy and breastfeeding. It is advised that individuals who are pregnant or breastfeeding consult a health professional before use. In animal studies, no teratogenic effects were reported, and no increase in fetal malformations was observed.
Non-Teratogenic Effects
While some formulations of acetaminophen indicate potential severe skin reactions, such as skin reddening, blisters, and rash, no specific non-teratogenic effects have been detailed in the provided data.
Nonclinical Toxicology Section
The nonclinical toxicology data available indicates that acetaminophen does not cause adverse developmental outcomes in animal studies. Studies have shown that acetaminophen is safe when used as directed and does not produce significant toxicity at therapeutic doses.
Animal Pharmacology and Toxicology
Animal studies have demonstrated that acetaminophen does not produce teratogenic effects and is safe at recommended doses. No significant toxicity was observed in animals, and no adverse developmental outcomes were reported.
Storage and Handling
The product is supplied in various forms including tablets (coated, film-coated, extended release, chewable), suspensions, solutions, and suppositories.
Tablets are typically stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with some products allowing excursions between 15°C to 30°C (59°F to 86°F). It is important to avoid high humidity and protect from light. Specific handling instructions include retaining the carton for complete product information and checking for tamper-evident seals.
Suspensions and solutions should also be stored at 20°C to 25°C (68°F to 77°F) and must not be refrigerated. Additionally, these products should be protected from freezing and light. Users should ensure that the printed neckband or seals are intact before use.
For all forms, it is crucial to adhere to the expiration date indicated on the packaging and to discard any product if the packaging is damaged or if seals are broken.
Product Labels
The table below lists all over-the-counter labels containing acetaminophen. Use it to compare dosage forms, strengths, and uses across products.
More Details | |||||
|---|---|---|---|---|---|
Sixarp, LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Whole Foods Market, INC. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
AMERISOURCE BERGEN | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
AMERISOURCE BERGEN | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
KROGER COMPANY | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
STRATEGIC SOURCING SERVICES LLC | Tablet, Extended Release | Oral | 650 mg | 2023 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
DOLGENCORP, INC. | Tablet, Extended Release | Oral | 650 mg | 2023 | |
Indications
| |||||
CVS Pharmacy | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
DOLGENCORP, INC. | Tablet, Extended Release | Oral | 650 mg | 2023 | |
Indications
| |||||
FSA STORE INC. | Tablet, Extended Release | Oral | 650 mg | 2023 | |
Indications
| |||||
HARRIS TEETER | Tablet, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
CVS Pharmacy | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
FSA STORE INC. | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
TARGET CORPORATION | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
GRIMANN SA DE CV | Capsule, Coated | Oral | 500 mg/1 U | 2021 | |
| |||||
Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals | Tablet, Effervescent | Oral | 500 mg | 2020 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Coated | Oral | 500 mg | 2012 | |
Indications
| |||||
AARNA USA INC. | Tablet | Oral | 325 mg | 2025 | |
Indications
| |||||
AARNA USA INC. | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Accudial Pharmaceutical, Inc. | Liquid | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Acino Products, LLC | Suppository | Rectal | 650 mg | 2015 | |
Indications
| |||||
Acino Products, LLC | Suppository | Rectal | 120 mg | 2015 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet | Oral | 325 mg | 1989 | |
Indications
| |||||
Akron Pharma Inc. | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
Akron Pharma Inc. | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Akron Pharma Inc. | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
Akron Pharma Inc. | Elixir | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Akron Pharma Inc. | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Akron Pharma Inc. | Elixir | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
American Health Packaging | Solution | Oral | 325 mg/10.15 mL | 2023 | |
Indications
| |||||
American Health Packaging | Solution | Oral | 650 mg/20.3 mL | 2023 | |
Indications
| |||||
American Sales Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
AMERIFOODS TRADING COMPANY | Tablet, Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
Amerisource Bergen | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Amerisource Bergen | Tablet, Coated | Oral | 325 mg | 2015 | |
Indications
| |||||
ARMY AND AIR FORCE EXCHANGE SERVICE | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
ARMY AND AIR FORCE EXCHANGE SERVICE | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
Aurohealth LLC | Tablet, Extended Release | Oral | 650 mg | 2016 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 160 mg | 2022 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Aurohealth LLC | Tablet, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
Belleview Biosciences LLC | Solution | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
BETTER LIVING BRANDS LLC. | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
BETTER LIVING BRANDS LLC. | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Better Living Brands, LLC | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
Bi-Mart | Tablet, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
BIG LOTS STORES, INC. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
BIG LOTS STORES, INC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
BluePoint Laboratories | Tablet | Oral | 650 mg | 2021 | |
Indications
| |||||
Bonita Pharmaceuticals LLC | Tablet, Coated | Oral | 500 mg | 2013 | |
Indications
| |||||
Cardinal Health 107, LLC | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Cardinal Health 107, LLC | Solution | Oral | 650 mg/20.3 mL | 2007 | |
Indications
| |||||
Cardinal Health 107, LLC | Tablet | Oral | 325 mg | 2018 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
Chain Drug Consortium, LLC | Tablet | Oral | 325 mg | 2016 | |
Indications
| |||||
Chain Drug Consortium, LLC | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC. | Syrup | Oral | 500 mg/15 mL | 2023 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Cispharma, Inc | Tablet | Oral | 325 mg | 2011 | |
Indications
| |||||
Cispharma, Inc | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
Cispharma, Inc | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
COSTCO WHOLESALE CORPORATION | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
CVS HEALTH CORP | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
CVS PHARMACY | Solution | Oral | 1000 mg/30 mL | 2021 | |
Indications
| |||||
CVS PHARMACY | Tablet, Coated | Oral | 325 mg | 2015 | |
Indications
| |||||
CVS PHARMACY | Tablet, Film Coated | Oral | 500 mg | 2005 | |
Indications
| |||||
CVS Pharmacy | Tablet, Extended Release | Oral | 650 mg | 2012 | |
Indications
| |||||
CVS PHARMACY | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
CVS PHARMACY | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
CVS Pharmacy | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
CVS PHARMACY iNC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CVS PHARMACY INC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
CVS PHARMACY, INC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
CVS PHARMACY, INC | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
CVS PHARMACY, INC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
CVS PHARMACY, INC | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
CVS Pharmacy, Inc | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
CVS Pharmacy, Inc. | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
CVS Pharmacy, Inc. | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
CVS Pharmacy, Inc. | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CVS Pharmacy, Inc. | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Solution | Oral | 1000 mg/30 mL | 2024 | |
Indications
| |||||
FAMILY DOLLAR | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
FAMILY DOLLAR | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
FAMILY DOLLAR | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Family Dollar Services, Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
FFREDS, INC | Capsule | Oral | 500 mg | 2017 | |
Indications
| |||||
FOODHOLD U. S. A. , LLC | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
FOODHOLD U. S. A. , LLC | Capsule, Liquid Filled | Oral | 325 mg | 2016 | |
Indications
| |||||
Fred's Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2004 | |
Indications
| |||||
FREDS, INC | Capsule | Oral | 500 mg | 2017 | |
Indications
| |||||
FSA STORE INC. | Tablet, Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
FSA Store Inc. | Tablet, Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
GERI-CARE PHARMACEUTICAL CORP | Tablet, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
Granules India Limited | Tablet, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
Granules India Limited | Tablet | Oral | 500 mg | 2017 | |
| |||||
Granules Pharmaceuticals Inc. | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
Granules Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Granules USA, Inc | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
Granules USA, Inc | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Granules USA, Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
Grocery Outlet, Inc. | Tablet | Oral | 325 mg | 2026 | |
Indications
| |||||
Grocery Outlet, Inc. | Tablet, Coated | Oral | 500 mg | 2026 | |
Indications
| |||||
H-E-B | Tablet, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
H. J. Harkins Company, Inc. | Liquid | Oral | 160 mg/5 mL | 1994 | |
Indications
| |||||
HARRIS TEETER | Tablet, Coated | Oral | 500 mg | 2013 | |
Indications
| |||||
Harris Teeter | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
HARRIS TEETER | Tablet, Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
HARRIS TEETER | Tablet, Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
HARRIS TEETER | Tablet | Oral | 325 mg | 2013 | |
Indications
| |||||
Health Mart | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Health Pharma USA LLC | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
HealthRight Products, LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Hi-Tech Nutraceuticals, LLC | Tablet | Oral | 325 mg | 2020 | |
| |||||
HIMPRIT PHARMACHEM PVT LTD | Tablet, Film Coated | Oral | 500 mg | 2010 | |
Indications
| |||||
Kareway Product, Inc. | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
Kroger Company | Tablet, Film Coated | Oral | 500 mg | 2015 | |
Indications
| |||||
Kroger Company | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
KROGER COMPANY | Tablet, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
Kroger Company | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Kroger Company | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Major Pharmaceuticals | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Major Pharmaceuticals | Solution | Oral | 160 mg/5 mL – 650 mg/20.3 mL | 2023 | |
Indications
| |||||
Major Pharmaceuticals | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Major Pharmaceuticals | Tablet | Oral | 325 mg | 2018 | |
Indications
| |||||
Major Pharmaceuticals | Solution | Oral | 1000 mg/30 mL | 2021 | |
Indications
| |||||
MAJOR PHARMACEUTICALS | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
Marlex Pharmaceuticals Inc | Tablet | Oral | 500 mg | 2026 | |
Indications
| |||||
Marlex Pharmaceuticals Inc | Tablet | Oral | 500 mg | 1997 | |
Indications
| |||||
McKesson | Tablet | Oral | 0.5 g/1 g | 2020 | |
Indications
| |||||
Meijer | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Meijer | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
MEIJER DISTRIBUTION INC | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
MEIJER DISTRIBUTION INC | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
MEIJER, INC. | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
Ohm Laboratories Inc. | Tablet, Extended Release | Oral | 650 mg | 2012 | |
Indications
| |||||
Oncor Pharmaceuticals | Liquid | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Padagis Israel Pharmaceuticals Ltd | Suppository | Rectal | 120 mg | 2010 | |
Indications
| |||||
Padagis Israel Pharmaceuticals Ltd | Suppository | Rectal | 650 mg | 2010 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Solution | Oral | 650 mg/20.3 mL | 2025 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Solution | Oral | 325 mg/10.15 mL | 2025 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Solution | Oral | 160 mg/5 mL – 650 mg/20.3 mL | 2007 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Suspension | Oral | 160 mg/5 mL – 650 mg/20.3 mL | 2021 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Solution | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Pharmacy Value Alliance, LLC | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
PHARMACY VALUE ALLIANCE, LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
Precision Dose, Inc. | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Prostat First Aid | Tablet | Oral | 325 mg | 2025 | |
Indications
| |||||
Prostat First Aid | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
PUBLIX SUPERMARKETS, INC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
PUBLIX SUPERMARKETS, INC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
PUBLIX SUPERMARKETS, INC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Rapid Care, Inc | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Rescuers Life sciences Limited | Tablet | Oral | 500 mg | 2020 | |
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
RETAIL BUSINESS SERVICES, LLC. | Tablet, Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
Rising Pharma Holdings, Inc. | Solution | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Rising Pharma Holdings, Inc. | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Rising Pharma Holdings, Inc. | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
RITE AID | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
RITE AID | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
RITE AID | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
Rite Aid Corporation | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Rugby Laboratories | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Rugby Laboratories | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Rugby Laboratories | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
Safetec of America, Inc. | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
Safeway Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Safeway Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2015 | |
Indications
| |||||
Safrel Pharmaceuticals, LLC. | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Safrel Pharmaceuticals, LLC. | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Safrel Pharmaceuticals, LLC. | Tablet, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
SAM'S WEST INC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Sam's West Inc | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Sam's West Inc | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
SAM'S WEST INC | Tablet | Oral | 650 mg | 2022 | |
Indications
| |||||
SAMJAN GROUP INC. | Liquid | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Select Brand | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Shopko Stores Operating Co. , LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
Softgel Healthcare Pvt Ltd | Capsule, Liquid Filled | Oral | 500 mg | 2025 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet | Oral | 325 mg | 2020 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet | Oral | 325 mg | 2018 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet | Oral | 325 mg | 2017 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet | Oral | 325 mg | 2011 | |
Indications
| |||||
Strive Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
SUPERVALU INC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2004 | |
Indications
| |||||
TARGET CORPORATION | Tablet, Film Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
TARGET CORPORATION | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
TARGET CORPORATION | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
TDS Pharm Co. , Ltd | Tablet | Oral | 500 mg | 2010 | |
Indications
| |||||
TIME CAP LABORATORIES, INC | Tablet, Film Coated | Oral | 500 mg | 2012 | |
Indications
| |||||
TIME CAP LABORATORIES, INC | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
TIME CAP LABS INC | Tablet | Oral | 325 mg | 2011 | |
Indications
| |||||
TIME CAP LABS INC | Tablet, Film Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
TOPCO ASSOCIATES LLC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Trifecta Pharmaceuticals USA LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Trifecta Pharmaceuticals USA LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
UNFI | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet | Oral | 325 mg | 2014 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Coated | Oral | 500 mg | 2013 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
Velocity Pharma | Tablet | Oral | 500 mg | 2012 | |
Indications
| |||||
Velocity Pharma LLC | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
WAL-MART STORES INC | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
WAL-MART STORES INC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
WAL-MART STORES INC | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Film Coated | Oral | 500 mg | 2005 | |
Indications
| |||||
WAL-MART STORES INC | Tablet | Oral | 650 mg | 2022 | |
Indications
| |||||
Wal-Mart Stores, Inc | Tablet, Extended Release | Oral | 650 mg | 2013 | |
Indications
| |||||
WALGREEN CO. | Tablet | Oral | 500 mg/500 1 | 2020 | |
Indications
| |||||
WALGREEN CO. | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
WALGREEN CO. | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
WALGREEN CO. | Tablet | Oral | 160 mg | 2021 | |
Indications
| |||||
WALGREEN CO. | Tablet, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Walgreen Company | Tablet, Extended Release | Oral | 650 mg | 2016 | |
Indications
| |||||
Walgreens | Tablet | Oral | 650 mg | 2024 | |
Indications
| |||||
WALGREENS | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
WALGREENS CO. | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
WALGREENS CO. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
Walgreens Co. | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Walmart | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
WALMART INC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
WALMART INC. | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
Westminster Pharmaceuticals, LLC | Liquid | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Wildman Business Group | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
WinCo Foods, LLC | Tablet | Oral | 325 mg | 2014 | |
Indications
| |||||
WinCo Foods, LLC | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Humanwell PuraCap Pharmaceutical (Wuhan) , Ltd. | Capsule, Liquid Filled | Oral | 325 mg | 2013 | |
Indications
| |||||
Humanwell PuraCap Pharmaceutical (Wuhan) Co. , Ltd | Capsule, Liquid Filled | Oral | 325 mg | 2016 | |
Indications
| |||||
One2zee Limited Liability Company | Capsule, Liquid Filled | Oral | 325 mg | 2019 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Granules India Limited | Tablet | Oral | 325 mg | 2017 | |
| |||||
Reliable 1 Laboratories LLC | Tablet | Oral | 325 mg | 2015 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 325 mg | 2016 | |
Indications
| |||||
Marlex Pharmaceuticals Inc | Tablet | Oral | 325 mg | 2026 | |
Indications
| |||||
Marlex Pharmaceuticals Inc | Tablet | Oral | 325 mg | 2018 | |
Indications
| |||||
Granules India Limited | Tablet | Oral | 500 mg | 2017 | |
| |||||
Granules India Limited | Tablet | Oral | 500 mg | 2023 | |
| |||||
NUVICARE LLC | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
NUVICARE LLC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Pioneer Life Sciences, LLC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Pioneer Life Sciences, LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Pioneer Life Sciences, LLC | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Reliable 1 Laboratories LLC | Tablet | Oral | 500 mg | 2015 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
Strive Pharmaceuticals Inc | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
CVS Pharmacy | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Supervalu Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2013 | |
Indications
| |||||
Breeden Brothers, LLC | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
GRAXCELL PHARMACEUTICAL, LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Coated | Oral | 500 mg | 2013 | |
Indications
| |||||
WinCo Foods, LLC | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Magno-Humphries, Inc. | Tablet | Oral | 650 mg | 2020 | |
Indications
| |||||
MARKSANS PHARMA LIMITED | Tablet, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
Aldama Pharmaceuticals, Inc | Solution | Oral | 500 mg/15 mL | 2026 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Better Living Brands LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Bi-Mart | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Family Dollar Stores, LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
KROGER COMPANY | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
KROGER COMPANY | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
KROGER COMPANY | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
WALMART INC. | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Kroger | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
TARGET CORPORATION | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Aldama Pharmaceuticals, Inc | Solution | Oral | 160 mg/5 mL | 2026 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
KROGER COMPANY | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
Magno-Humphries, Inc. | Tablet | Oral | 325 mg | 2020 | |
Indications
| |||||
Patrin Pharma, Inc. | Liquid | Oral | 160 mg/5 mL – 650 mg/20.3 mL | 2023 | |
Indications
| |||||
We Care Distributors Inc. | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
OPMX LLC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
TIME CAP LABORATORIES, INC. | Tablet, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
American Sales Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
RARITAN PHARMACEUTICALS INC | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Syntho Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Aurex Laboratories Limited Liability Company | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Aero Healthcare | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
Amazon. com Services LLC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Amazon. com Services LLC | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
Amazon. com Services LLC | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
Amazon. com Services LLC | Tablet | Oral | 500 mg | 2026 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet | Oral | 500 mg | 1990 | |
Indications
| |||||
Advance Pharmaceutical Inc. | Tablet | Oral | 500 mg | 1989 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2015 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2015 | |
Indications
| |||||
GERITREX LLC | Elixir | Oral | 160 mg/5 mL | 2018 | |
Indications
| |||||
Asclemed USA, Inc. | Tablet | Oral | 325 mg | 2020 | |
Indications
| |||||
A P J Laboratories Limited | Tablet | Oral | 500 mg | 2013 | |
Indications
| |||||
Western First Aid Safety DBA Aramark | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Safeway Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
AMERIFOODS TRADING COMPANY | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
BETTER LIVING BRANDS, LLC | Tablet, Extended Release | Oral | 650 mg | 2023 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
Grocery Outlet, Inc. | Tablet, Extended Release | Oral | 650 mg | 2026 | |
Indications
| |||||
HYVEE INC | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
SAFEWAY | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
SAM'S WEST INC | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
TARGET CORPORATION | Tablet | Oral | 650 mg | 2021 | |
Indications
| |||||
CHAIN DRUG CONSORTIUM | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
CVS PHARMACY | Tablet, Extended Release | Oral | 650 mg | 2014 | |
Indications
| |||||
CVS PHARMACY | Tablet, Extended Release | Oral | 650 mg | 2014 | |
Indications
| |||||
KROGER COMPANY | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
Meijer | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
Meijer Distribution Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2007 | |
Indications
| |||||
Publix Super Markets Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2007 | |
Indications
| |||||
TOPCO ASSOCIATES LLC | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
WINCO FOODS, LLC | Tablet, Extended Release | Oral | 650 mg | 2023 | |
Indications
| |||||
Aidarex Pharmaceuticals LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
P & L Development, LLC | Tablet | Oral | 650 mg | 2020 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2000 | |
Indications
| |||||
WALGREENS | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
P & L Development, LLC | Tablet | Oral | 650 mg | 2021 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Capsule, Gelatin Coated | Oral | 325 mg | 2016 | |
Indications
| |||||
OPMX LLC | Tablet, Coated | Oral | 650 mg | 2026 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Aurohealth LLC | Tablet | Oral | 325 mg | 2016 | |
Indications
| |||||
KROGER COMPANY | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
A-Z Pharma Group LLC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
DLC Laboratories, Inc. | Liquid | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Amazon. com Services LLC | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Amazon. com Services LLC | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Amazon. com Services LLC | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
Amazon. com Services LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
Amazon. com Services LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2021 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Amazon. com Services LLC | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
BJWC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
BJWC | Tablet, Film Coated | Oral | 500 mg | 2015 | |
Indications
| |||||
BJWC | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
BETTER LIVING BRANDS LLC | Suspension | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
Cabinet Health P. B. C. | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Calmour | Strip | Oral | 80 mg | 2025 | |
Indications
| |||||
American Sales Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2005 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 325 mg | 2016 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 500 mg | 2015 | |
Indications
| |||||
New World Imports, Inc | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
American Sales Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
American Sales Company | Tablet, Film Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
American Sales Company | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2018 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
American Sales Company | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
Retail Business Services, LLC | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
HART Health | Tablet | Oral | 325 mg | 1986 | |
Indications
| |||||
HART Health | Tablet | Oral | 500 mg | 1990 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Richmond Pharmaceuticals, Inc. | Tablet, Chewable | Oral | 80 mg | 2015 | |
Indications
| |||||
AARNA USA INC. | Liquid | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
MAJOR PHARMACEUTICALS | Liquid | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
VERITYRX. LLC | Liquid | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
MEIJER DISTRIBUTION INC | Tablet, Chewable | Oral | 160 mg | 2020 | |
Indications
| |||||
Target Corporation | Tablet, Chewable | Oral | 160 mg | 2019 | |
Indications
| |||||
Target Corporation | Tablet, Chewable | Oral | 160 mg | 2019 | |
Indications
| |||||
Allegiant Health | Tablet, Chewable | Oral | 160 mg | 2023 | |
Indications
| |||||
Accudial Pharmaceutical, Inc. | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Accudial Pharmaceutical, Inc. | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Accudial Pharmaceutical, Inc. | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Accudial Pharmaceutical, Inc. | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
AARNA USA INC. | Suspension | Oral | 160 mg/5 mL | 2025 | |
| |||||
AARNA USA INC. | Suspension | Oral | 160 mg/5 mL | 2025 | |
| |||||
Advagen Pharma Limited | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
ARMY AND AIR FORCE EXCHANGE SERVICE | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Cardinal Health 107, LLC | Suspension | Oral | 160 mg/5 mL | 2007 | |
Indications
| |||||
FSA Store Inc. (Caring Mills) | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Grocery Outlet, Inc. | Suspension | Oral | 160 mg/5 mL | 2026 | |
Indications
| |||||
Kesin Pharma Corporation | Suspension | Oral | 160 mg/5 mL | 2026 | |
Indications
| |||||
Major Pharmaceuticals | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Major Pharmaceuticals | Suspension | Oral | 160 mg/5 mL | 2023 | |
| |||||
Padagis Israel Pharmaceuticals Ltd | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Suspension | Oral | 160 mg/5 mL | 2007 | |
Indications
| |||||
R3 Pharmaceuticals, LLC | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
Rij Pharmaceutical Corporation | Suspension | Oral | 160 mg/5 mL | 1999 | |
Indications
| |||||
Rij Pharmaceutical Corporation | Elixir | Oral | 160 mg/5 mL | 1999 | |
Indications
| |||||
Rij Pharmaceutical Corporation | Elixir | Oral | 160 mg/5 mL | 1999 | |
Indications
| |||||
Rij Pharmaceutical Corporation | Suspension | Oral | 160 mg/5 mL | 1999 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
We Care Distributor Inc. | Elixir | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
We Care Distributors Inc. | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
WinCo Foods, LLC | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
We Care Distributor Inc. | Liquid | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
AARNA USA INC. | Liquid | Oral | 160 mg/5 mL | 2024 | |
| |||||
American Health Packaging | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Genexa Inc. | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
We Care Distributor Inc. | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
BLESSINGS INTERNATIONAL | Tablet, Chewable | Oral | 80 mg | 2022 | |
Indications
| |||||
Discount Drug Mart | Tablet, Chewable | Oral | 160 mg | 2020 | |
Indications
| |||||
GERI-CARE PHARMACEUTICAL CORP | Tablet, Chewable | Oral | 80 mg | 2024 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Chewable | Oral | 160 mg | 2023 | |
Indications
| |||||
Rite Aid Corporation | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Rite Aid Corporation | Suspension | Oral | 160 mg/5 mL | 1997 | |
Indications
| |||||
Rite Aid Corporation | Suspension | Oral | 160 mg/5 mL | 1997 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Chewable | Oral | 80 mg | 2004 | |
Indications
| |||||
Kareway Product, Inc. | Liquid | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Ballay Pharmaceuticals, Inc | Solution | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
AptaPharma Inc. | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
AptaPharma Inc. | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
AptaPharma Inc. | Liquid | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
Best Choice (Valu Merchandisers Company) | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Best Choice (Valu Merchandisers Company) | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CVS Pharmacy | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
CVS Pharmacy | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
CVS Pharmacy | Suspension | Oral | 160 mg/5 mL | 1991 | |
Indications
| |||||
CVS Pharmacy | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
CVS PHARMACY, INC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
CVS PHARMACY, INC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Discount Drug Mart | Liquid | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
HyVee Inc | Suspension | Oral | 160 mg/5 mL | 2026 | |
Indications
| |||||
KROGER COMPANY | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Kroger Company | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Marc Glassman, Inc. | Liquid | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 1998 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
TOPCO ASSOCIATES LLC | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Topco Associates, LLC | Tablet, Chewable | Oral | 160 mg | 2019 | |
Indications
| |||||
Topco Associates, LLC | Tablet, Chewable | Oral | 160 mg | 2019 | |
Indications
| |||||
Walgreen Company | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Walgreen Company | Suspension | Oral | 160 mg/5 mL | 1995 | |
Indications
| |||||
Walgreen Company | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
WALGREENS | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
WALGREENS CO. | Powder | Oral | 160 mg | 2020 | |
Indications
| |||||
Walgreen Company | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Tablet, Chewable | Oral | 160 mg | 2024 | |
Indications
| |||||
Walgreen Company | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
CVS PHARMACY | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Allegiant Health | Liquid | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Aurohealth LLC | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
Aurohealth LLC | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
Better Living Brands, LLC | Tablet, Chewable | Oral | 160 mg | 2023 | |
Indications
| |||||
Chain Drug Consortium (Premier Value) | Liquid | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Chain Drug Consortium (Premier Value) | Liquid | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Chain Drug Consortium (Premier Value) | Liquid | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
CVS Pharmacy, Inc. | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
Family Dollar Services Inc | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
H E B | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Kroger Company | Tablet, Chewable | Oral | 160 mg | 2021 | |
Indications
| |||||
Publix Super Markets Inc | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
QUALITY CHOICE (Chain Drug Marketing Association) | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Puro Pharma Inc. | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
WinCo Foods, LLC | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
WinCo Foods, LLC | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
BJWC (Berkley & Jensen / BJ's) | Suspension | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
H E B | Tablet, Chewable | Oral | 160 mg | 2022 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Genomma Lab USA, Inc. | Liquid | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Chewable | Oral | 160 mg | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Powder | Oral | 160 mg | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Chewable | Oral | 160 mg | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
Athlete's Needs, Inc. | Tablet | Oral | 500 mg | 2012 | |
Indications
| |||||
Athlete's Needs, Inc. | Tablet | Oral | 325 mg | 2013 | |
Indications
| |||||
Eagle Distributors, Inc. | Tablet | Oral | 500 mg | 2013 | |
Indications
| |||||
Melaleuca, Inc. | Tablet, Film Coated | Oral | 500 mg | 2016 | |
Indications
| |||||
Crane Safety LLC | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
OPMX LLC | Capsule, Gelatin Coated | Oral | 650 mg | 2026 | |
Indications
| |||||
Wittman Pharma, Inc. | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
CVS Pharmacy | Capsule | Oral | 500 mg | 2025 | |
Indications
| |||||
CVS Pharmacy | Capsule | Oral | 500 mg | 2025 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
CVS PHARMACY | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
CVS Pharrmacy | Capsule, Liquid Filled | Oral | 500 mg | 2019 | |
Indications
| |||||
Dolgencorp, LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
Dolgencorp Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2018 | |
Indications
| |||||
Dolgencorp Inc | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Dolgencorp Inc | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Dolgencorp, LLC | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Dolgencorp Inc | Tablet | Oral | 500 mg | 2014 | |
Indications
| |||||
Dolgencorp Inc | Tablet, Film Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
Dolgencorp, LLC | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Conney Safety Products, LLC | Tablet, Film Coated | Oral | 325 mg | 2013 | |
Indications
| |||||
Conney Safety Products, LLC | Tablet, Film Coated | Oral | 500 mg | 2013 | |
Indications
| |||||
Pharmadel LLC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
BENARD INDUSTRIES INC | Tablet | Oral | 650 mg | 2023 | |
Indications
| |||||
BENARD INDUSTRIES INC | Tablet, Film Coated | Oral | 500 mg | 2016 | |
Indications
| |||||
BENARD INDUSTRIES INC | Tablet, Film Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
Menper Distributors Inc. | Tablet | Oral | 325 mg | 2017 | |
Indications
| |||||
Menper Distributors, Inc. | Liquid | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Coated | Oral | 325 mg | 2008 | |
Indications
| |||||
CalmCo LLC | Solution | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Farmacias De Similares TX LLC | Tablet, Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Farmacias De Similares TX LLC | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Infirst Healthcare Inc. | Liquid | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
GADAL Laboratories, Inc | Syrup | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
CalmCo LLC | Bar, Chewable | Oral | 80 mg | 2023 | |
Indications
| |||||
Raritan Pharmaceuticals Inc. | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Menper Distributors Inc. | Tablet | Oral | 325 mg | 2017 | |
Indications
| |||||
PAI Holdings, LLC dba PAI Pharma | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Precision Dose Inc. | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
CVS | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
FAMILY DOLLAR SERVICES INC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
WALGREENS | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Walgreens | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Walgreens | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
P & L Development, LLC | Suspension | Oral | 160 mg/5 mL | 2018 | |
Indications
| |||||
Safeway, Inc. | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
WALGREEN COMPANY | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
Easyfast Supplements LLC | Capsule | Oral | 500 mg | 2023 | |
Indications
| |||||
EDWARDS PHARMACEUTICALS, INC. | Liquid | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet, Extended Release | Oral | 650 mg | 2022 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2016 | |
Indications
| |||||
WALMART INC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
Wal-Mart Stores Inc | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
Wal-Mart Stores Inc | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
WALMART INC. | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Wal-Mart Stores Inc | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Wal-Mart Stores Inc | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
WALMART INC. | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
WALMART INC. | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
WALMART INC. | Tablet, Film Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
Walmart Inc | Bar, Chewable | Oral | 250 mg | 2024 | |
Indications
| |||||
Walmart Inc | Bar, Chewable | Oral | 250 mg | 2024 | |
Indications
| |||||
America Medic & Science, LLC | Tablet, Delayed Release | Oral | 650 mg | 2019 | |
Indications
| |||||
America Medic & Science, LLC | Tablet, Delayed Release | Oral | 500 mg | 2020 | |
Indications
| |||||
America Medic & Science, LLC | Tablet, Delayed Release | Oral | 1000 mg | 2020 | |
Indications
| |||||
OPMX LLC | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
Major Pharmaceuticals | Liquid | Oral | 500 mg/15 mL | 2009 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet | Oral | 500 mg | 2010 | |
Indications
| |||||
Contract Pharmacy Services-PA | Tablet | Oral | 500 mg | 2010 | |
Indications
| |||||
CVS PHARMACY | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
CVS PHARMACY, INC. | Tablet, Film Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Grocery Outlet, Inc. | Tablet, Coated | Oral | 500 mg | 2026 | |
Indications
| |||||
Hi-Tech Nutraceuticals, LLC | Tablet | Oral | 500 mg | 2020 | |
| |||||
PuraCap Pharmaceutical LLC | Tablet, Film Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
RITE AID CORPORATION | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
SAM'S WEST INC | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
SAVE-A-LOT FOOD STORES, LTD. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Spirit Pharmaceutical LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
TIME CAP LABORATORIES, INC. | Tablet | Oral | 500 mg | 2026 | |
Indications
| |||||
TIME CAP LABORATORIES, INC. | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
WALGREENS CO. | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Walgreens Company | Tablet | Oral | 500 mg | 2020 | |
| |||||
Aidarex Pharmaceuticals LLC | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
THE KROGER CO | Capsule, Liquid Filled | Oral | 500 mg | 2026 | |
Indications
| |||||
Safrel Pharmaceuticals, LLC. | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Strategic Sourcing Services, LLC | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet | Oral | 500 mg | 2014 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet | Oral | 500 mg | 1989 | |
Indications
| |||||
GERI-CARE PHARMACEUTICAL CORP | Suspension | Oral | 500 mg/15 mL | 2019 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Capsule, Gelatin Coated | Oral | 500 mg | 2007 | |
Indications
| |||||
Gobrands, Inc | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Kmart Corporation | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
PuraCap Pharmaceutical LLC | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
PuraCap Pharmaceutical LLC | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 2005 | |
Indications
| |||||
Topco Associates LLC | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Coated | Oral | 500 mg | 2009 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet | Oral | 500 mg | 2009 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet, Coated | Oral | 500 mg | 2007 | |
Indications
| |||||
BIG LOTS STORES, INC. | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
INGLES MARKETS, INC. | Tablet | Oral | 500 mg | 2006 | |
Indications
| |||||
INGLES MARKETS, INC. | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
INGLES MARKETS, INC. | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
Mechanical Servants LLC | Tablet | Oral | 500 | 2019 | |
Indications
| |||||
PuraCap Pharmaceutical LLC | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Walmart Inc. | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Family Dollar Services, Inc. | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Randob Labs. , Ltd. | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
CVS Pharmacy | Suppository | Rectal | 120 mg | 2010 | |
Indications
| |||||
Sun Pharmaceutical Industries, Inc. | Suppository | Rectal | 325 mg | 2013 | |
Indications
| |||||
Sun Pharmaceutical Industries, Inc. | Suppository | Rectal | 80 mg | 2013 | |
Indications
| |||||
Sun Pharmaceutical Industries, Inc. | Suppository | Rectal | 120 mg | 2013 | |
Indications
| |||||
Sun Pharmaceutical Industries, Inc. | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
TARO PHARMACEUTICALS U. S. A. , INC. | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
USpharma Ltd | Tablet, Chewable | Oral | 80 mg | 2026 | |
Indications
| |||||
FORTUNE PHARMACAL COMPANY, LIMITED | Tablet | Oral | 500 mg | 2004 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suppository | Rectal | 120 mg | 2025 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suppository | Rectal | 650 mg | 2025 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Film Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Strategic Sourcing Services LLC | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Genexa Inc. | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Genexa Inc. | Tablet, Chewable | Oral | 80 mg | 2022 | |
Indications
| |||||
Genexa Inc. | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Genexa, Inc. | Tablet, Chewable | Oral | 80 mg | 2022 | |
Indications
| |||||
Geri-Care Pharmaceuticals, Corp | Liquid | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
Menper Distributors, Inc. | Liquid | Oral | 675 mg/15 mL | 2012 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 1998 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Amerisource Bergen | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Amerisource Bergen | Tablet, Film Coated | Oral | 500 mg | 2015 | |
Indications
| |||||
Amerisource Bergen | Tablet | Oral | 500 mg | 1989 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1989 | |
Indications
| |||||
L. Perrigo Company | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
L. Perrigo Company | Suspension | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
L. Perrigo Company | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
L. Perrigo Company | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
L. Perrigo Company | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
L. Perrigo Company | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
L. Perrigo Company | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2005 | |
Indications
| |||||
L. Perrigo Company | Tablet, Film Coated | Oral | 500 mg | 2015 | |
Indications
| |||||
L. Perrigo Company | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
L. Perrigo Company | Tablet | Oral | 500 mg | 1989 | |
Indications
| |||||
L. Perrigo Company | Tablet | Oral | 325 mg | 1989 | |
Indications
| |||||
L. Perrigo Company | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1989 | |
Indications
| |||||
Aidarex Pharmaceuticals LLC | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
Cabinet Health P. B. C. | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Gobrands, Inc | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
Unifirst First Aid Corporation |
| Oral | 500 mg | 2023 | |
Indications
| |||||
Harris Teeter, LLC | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
No More Pills, LLC | Liquid | Oral | 650 mg/50 mL | 2020 | |
Indications
| |||||
MATERNAL SCIENCE, LLC | Tablet | Oral | 500 mg | 2013 | |
Indications
| |||||
HEB | Tablet, Extended Release | Oral | 650 mg | 2020 | |
Indications
| |||||
Help Remedies, Inc. | Tablet | Oral | 325 mg | 2012 | |
| |||||
Henry Schein, Inc. | Tablet, Film Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
Henry Schein, Inc. | Tablet, Film Coated | Oral | 325 mg | 2008 | |
Indications
| |||||
Rite Aid Corporation | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Rite Aid Corporation | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
CVS Pharmacy | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
KinderFarms, LLC | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
KinderFarms, LLC | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Kroger Company | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Walgreen Company | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
WALGREEN COMPANY | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
WALGREENS | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Genexa Inc. | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
H E B | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
H E B | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Chain Drug Consortium (Premier Value) | Liquid | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Publix Super Markets Inc | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Publix Super Markets Inc | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
WinCo Foods, LLC | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Pharmacy Value Alliance, LLC | Suspension | Oral | 160 mg/5 mL | 2018 | |
Indications
| |||||
Rij Pharmaceutical Corporation | Suspension | Oral | 160 mg/1.6 mL | 1999 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
Chain Drug Consortium | Tablet, Orally Disintegrating | Oral | 160 mg | 2015 | |
Indications
| |||||
Capricorn Pharma Inc. | Tablet | Oral | 160 mg | 2010 | |
Indications
| |||||
Genexa Inc. | Liquid | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Genexa Inc. | Liquid | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Genexa Inc. | Liquid | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
KinderFarms, LLC | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Costco Wholesale Company | Tablet | Oral | 500 mg | 2009 | |
Indications
| |||||
Mollec Inc | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
KROGER COMPANY | Tablet, Chewable | Oral | 160 mg | 2024 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Suspension | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Suspension | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Suspension | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
Cardinal Health | Capsule, Liquid Filled | Oral | 500 mg | 2019 | |
Indications
| |||||
Cardinal Health 110, LLC. dba Leader | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Suspension | Oral | 160 mg/5 mL | 2014 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
KRAMER NOVIS | Liquid | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | Liquid | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
Medtech Products Inc. | Liquid | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Medtech Products Inc. | Liquid | Oral | 160 mg/5 mL | 2010 | |
Indications
| |||||
Medtech Products Inc. | Liquid | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Llorens Pharmaceutical International Division, Inc. | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Method Pharmaceuticals, LLC | Liquid | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Method Pharmaceuticals, LLC | Liquid | Oral | 160 mg/5 mL | 2019 | |
Indications
| |||||
VERITYRX, LLC | Liquid | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Major Pharmaceuticals | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2019 | |
Indications
| |||||
Major Pharmaceuticals | Liquid | Oral | 500 mg/15 mL | 2025 | |
Indications
| |||||
Aidarex Pharmaceuticals LLC | Tablet | Oral | 325 mg | 2011 | |
Indications
| |||||
Major Pharmaceuticals | Capsule | Oral | 500 mg | 1997 | |
Indications
| |||||
Akron Pharma Inc. | Liquid | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Akron Pharma Inc. | Suspension | Oral | 160 mg/5 mL | 2024 | |
| |||||
Akron Pharma Inc. | Liquid | Oral | 160 mg/5 mL | 2024 | |
| |||||
Akron Pharma Inc. | Suspension | Oral | 160 mg/5 mL | 2024 | |
| |||||
Akron Pharma Inc. | Liquid | Oral | 160 mg/5 mL | 2024 | |
| |||||
ATLANTIC BIOLOGICALS CORP. | Liquid | Oral | 160 mg/5 mL | 2024 | |
| |||||
ATLANTIC BIOLOGICALS CORP. | Liquid | Oral | 160 mg/5 mL | 2024 | |
| |||||
JHK Inc dba American Safety & First Aid | Tablet | Oral | 500 mg | 2000 | |
Indications
| |||||
McKesson Medical-Surgical, Inc. | Tablet, Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
The Medicine Shoppe International | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Coated | Oral | 325 mg | 2021 | |
Indications
| |||||
Sportpharm, Inc. dba Sportpharm | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Unifirst First Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Medline Industries, LP | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
Medline Industries, LP | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Medline Industries, LP | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Medline Industries, LP | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
MEIJER DISTRIBUTION INC | Tablet, Chewable | Oral | 160 mg | 2020 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
OPMX Chula Vista | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
OPMX LLC | Tablet, Chewable | Oral | 160 mg | 2026 | |
Indications
| |||||
Sam's West Inc | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Sam's West Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2005 | |
Indications
| |||||
Sam's West Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
Bayer HealthCare LLC. | Tablet, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
Mom Enterprises, LLC. | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Mom Enterprises, LLC. | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
OPMX Chula Vista | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
ADVANCED FIRST AID, INC. | Tablet | Oral | 500 | 2015 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Etex Pharm Co. , Ltd | Tablet | Oral | 500 mg | 2010 | |
Indications
| |||||
Genuine First Aid LLC | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
Redicare LLC | Tablet | Oral | 500 mg | 2017 | |
| |||||
Ballay Pharmaceuticals, Inc | Solution/ Drops | Oral | 80 mg/0.8 mL | 1997 | |
Indications
| |||||
VIVUNT PHARMA LLC | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
VIVUNT PHARMA LLC | Tablet | Oral | 650 mg | 2022 | |
Indications
| |||||
HBC Pharma, LLC | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
MEDWISE LIFESCIENCES INC. | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
MEDWISE LIFESCIENCES INC. | Suspension | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
O4 Global Trading Usa, Llc | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
O4 Global Trading Usa, Llc | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Accudial Pharmaceutical, Inc. | Suspension | Oral | 160 mg/5 mL | 2010 | |
Indications
| |||||
CVS Pharmacy | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | Tablet, Chewable | Oral | 160 mg | 2025 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet, Chewable | Oral | 160 mg | 2018 | |
Indications
| |||||
H E B | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
KinderFarms, LLC | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Kroger Company | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
Meijer Distribution Inc | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
P & L Development, LLC | Suspension | Oral | 160 mg/5 mL | 2016 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Walgreen Company | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet | Oral | 325 mg | 2012 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
AAA Pharmaceutical, Inc. | Tablet, Coated | Oral | 500 mg | 2015 | |
Indications
| |||||
Allegiant Health | Capsule, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 500 mg | 2014 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Allegiant Health | Tablet, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
AMERICAN SALES COMPANY | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
AMERISOURCE BERGEN | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Amerisource Bergen | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
AmeriSource Bergen | Tablet | Oral | 325 mg | 2017 | |
Indications
| |||||
BETTER LIVING BRANDS LLC. | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
BETTER LIVING BRANDS LLC. | Tablet | Oral | 325 mg | 2023 | |
Indications
| |||||
CHAIN DRUG CONSORTIUM | Tablet, Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet | Oral | 500 mg | 2014 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet, Coated | Oral | 500 mg | 2007 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet, Coated | Oral | 500 mg | 2012 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet | Oral | 325 mg | 2014 | |
Indications
| |||||
Chain Drug Marketing Association | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION, INC. | Tablet, Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
CVS PHARMACY | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
CVS PHARMACY | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Demoulas Super Markets, Inc | Tablet | Oral | 325 mg | 2012 | |
Indications
| |||||
Demoulas Super Markets, Inc | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Demoulas Super Markets, Inc | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Coated | Oral | 500 mg | 2007 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Coated | Oral | 500 mg | 2010 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
DISCOUNT DRUG MART | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
DOLGENCORP, LLC | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | Liquid | Oral | 500 mg/15 mL | 2015 | |
Indications
| |||||
GoodSense | Tablet, Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
H E B | Suspension | Oral | 160 mg/5 mL | 1996 | |
Indications
| |||||
H E B | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
H E B | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
H E B | Tablet | Oral | 500 mg | 1991 | |
Indications
| |||||
HEB | Tablet, Coated | Oral | 500 mg | 2013 | |
Indications
| |||||
HEB | Tablet, Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
HyVee Inc | Tablet | Oral | 500 mg | 1991 | |
Indications
| |||||
HyVee Inc | Tablet | Oral | 500 mg | 1996 | |
Indications
| |||||
HYVEE INC | Tablet | Oral | 325 mg | 2025 | |
Indications
| |||||
HYVEE INC | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
HYVEE INC | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
HYVEE INC | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
HYVEE INC | Tablet, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
HYVEE INC | Tablet, Extended Release | Oral | 650 mg | 2025 | |
Indications
| |||||
HyVee Inc | Tablet, Film Coated | Oral | 500 mg | 2026 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet | Oral | 325 mg | 2022 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
MARC GLASSMAN, INC. | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Meijer | Tablet | Oral | 325 mg | 2012 | |
Indications
| |||||
MEIJER | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Meijer Distribution Inc | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
Meijer Distribution Inc | Tablet | Oral | 500 mg | 1993 | |
Indications
| |||||
Meijer Distribution Inc | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
Meijer Distribution Inc | Tablet | Oral | 500 mg | 1995 | |
Indications
| |||||
Meijer Distribution Inc | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
Meijer Distribution, Inc. | Solution | Oral | 1000 mg/30 mL | 2021 | |
Indications
| |||||
Meijer, Inc. | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
P & L Development, LLC | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
P & L Development, LLC | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
Publix Super Markets Inc | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
PUBLIX SUPER MARKETS INC | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Publix Super Markets Inc | Tablet | Oral | 500 mg | 1988 | |
Indications
| |||||
QUALITY CHOICE (Chain Drug Marketing Association) | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
QUALITY CHOICE (Chain Drug Marketing Association) | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Rite Aid Corporation | Tablet | Oral | 325 mg | 1990 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
Safeway | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
SAFEWAY | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
STRATEGIC SOURCING SERVICES LLC | Tablet | Oral | 325 mg | 2023 | |
Indications
| |||||
STRATEGIC SOURCING SERVICES LLC | Tablet, Coated | Oral | 500 mg | 2023 | |
Indications
| |||||
STRATEGIC SOURCING SERVICES LLC | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
TopCo Associates LLC | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
TopCo Associates LLC | Tablet | Oral | 325 mg | 2011 | |
Indications
| |||||
TopCo Associates LLC | Tablet, Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Topco Associates, LLC | Tablet, Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
Topco Associates, LLC | Tablet, Film Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
H E B | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
Rite Aid Corporation | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
CVS PHARMACY, INC. | Capsule, Liquid Filled | Oral | 500 mg | 2016 | |
Indications
| |||||
Humanwell PuraCap Pharmaceutical (Wuhan) , Ltd. | Capsule, Liquid Filled | Oral | 500 mg | 2014 | |
Indications
| |||||
Select Corporation | Tablet | Oral | 500 mg | 2012 | |
Indications
| |||||
TOPCO ASSOCIATES LLC | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Ellywell, LLC | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Safeway | Tablet, Coated | Oral | 500 mg | 2015 | |
Indications
| |||||
Allegiant Health | Tablet | Oral | 500 mg | 2014 | |
Indications
| |||||
Better Living Brands, LLC | Solution | Oral | 1000 mg/30 mL | 2021 | |
Indications
| |||||
CHAIN DRUG CONSORTIUM | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Chain Drug Consortium | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Family Dollar (FAMILY WELLNESS) | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Family Dollar (FAMILY WELLNESS) | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
H E B | Tablet, Chewable | Oral | 160 mg | 2005 | |
Indications
| |||||
Health Pharma USA LLC | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
HHH PHARMA USA LLC | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Film Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
L. N. K. International, Inc. | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
LIDL US LLC | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Magno-Humphries, Inc. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Marc Glassman, Inc. | Tablet | Oral | 325 mg | 2008 | |
Indications
| |||||
Marc Glassman, Inc. | Tablet, Coated | Oral | 500 mg | 2008 | |
Indications
| |||||
P & L Development, LLC | Liquid | Oral | 500 mg/15 mL | 2019 | |
Indications
| |||||
P & L Development, LLC | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
QUALITY CHOICE (Chain Drug Marketing Association) | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Rite Aid Corporation | Solution | Oral | 1000 mg/30 mL | 2023 | |
Indications
| |||||
Rite Aid Corporation | Liquid | Oral | 500 mg/15 mL | 2020 | |
Indications
| |||||
Salado Sales, Inc. | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
Shield Pharmaceuticals Corp | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
Strategic Sourcing Services LLC | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Valu Merchandisers Company | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
WAL-MART STORES INC | Tablet, Film Coated | Oral | 325 mg | 2022 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
Wal-Mart Stores Inc | Tablet, Film Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
WALGREEN CO. | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
WALGREEN CO. | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Walgreen Company | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
Walgreen Company | Tablet | Oral | 500 mg | 2009 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Walgreen Company | Tablet, Film Coated | Oral | 500 mg | 1993 | |
Indications
| |||||
Walgreen Company | Tablet, Coated | Oral | 500 mg | 2004 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Walgreens | Capsule, Liquid Filled | Oral | 500 mg | 2025 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
WALGREENS | Tablet, Film Coated | Oral | 500 mg | 2026 | |
Indications
| |||||
Walgreens | Chewable Gel | Oral | 500 mg | 2026 | |
Indications
| |||||
Walgreens | Liquid | Oral | 500 mg/15 mL | 2016 | |
Indications
| |||||
WALGREENS | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Walgreens | Capsule, Liquid Filled | Oral | 500 mg | 2024 | |
Indications
| |||||
WALGREENS CO. | Tablet, Film Coated | Oral | 325 mg | 2022 | |
Indications
| |||||
Walmart Inc. | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
WALMART INC. (see also Equate) | Suspension | Oral | 160 mg/5 mL | 2022 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
TIME CAP LABORATORIES, INC. | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
CVS Pharmacy | Liquid | Oral | 500 mg/15 mL | 2018 | |
Indications
| |||||
Walgreen Company | Suppository | Rectal | 120 mg | 2010 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Film Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet | Oral | 500 mg | 2023 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet | Oral | 500 mg | 2022 | |
Indications
| |||||
Haleon US Holdings LLC | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Haleon US Holdings LLC | Tablet, Film Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Haleon US Holdings LLC | Tablet, Film Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
Haleon US Holdings LLC | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Wal-Mart Stores Inc | Suspension | Oral | 160 mg/5 mL | 2017 | |
Indications
| |||||
SJ INCORPORATION LTD | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
RANDOB LABS, LTD. DBA CROSSINGWELL CONSUMER HEALTH | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
RANDOB LABS, LTD. DBA CROSSINGWELL CONSUMER HEALTH | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Blacksmith Brands, Inc. | Liquid | Oral | 80 mg/0.8 mL | 2010 | |
Indications
| |||||
Medtech Products Inc. | Liquid | Oral | 160 mg/5 mL | 2013 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2006 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet, Coated | Oral | 500 mg | 2018 | |
Indications
| |||||
Pharbest Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2007 | |
Indications
| |||||
Ulai Health LLC | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Ulai Health LLC | Tablet, Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
Ulai Health LLC | Tablet | Oral | 500 mg | 2019 | |
Indications
| |||||
Acme United Corporation | Tablet, Film Coated | Oral | 500 mg | 2012 | |
Indications
| |||||
Premier Value | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Chain Drug Consortium, LLC | Tablet, Extended Release | Oral | 650 mg | 2012 | |
Indications
| |||||
Chain Drug Consortium, LLC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Chain Drug Consortium | Tablet, Chewable | Oral | 80 mg | 2004 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1988 | |
Indications
| |||||
Advanced Rx LLC | Liquid | Oral | 500 mg/15 mL | 2025 | |
Indications
| |||||
Advanced Rx LLC | Liquid | Oral | 500 mg/15 mL | 2024 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Liquid | Oral | 500 mg/15 mL | 2020 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Liquid | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Lab Safety Supply, Inc. | Tablet, Film Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
Lab Safety Supply, Inc. | Tablet, Film Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
Lab Safety Supply, Inc. | Tablet, Film Coated | Oral | 325 mg | 2011 | |
Indications
| |||||
Lab Safety Supply, Inc. | Tablet, Film Coated | Oral | 325 mg | 2011 | |
Indications
| |||||
Publix Super Markets Inc | Tablet, Film Coated | Oral | 500 mg | 2016 | |
Indications
| |||||
Pharmadel LLC | Capsule, Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Pharmadel LLC | Tablet | Oral | 500 mg | 2024 | |
Indications
| |||||
Redicare LLC | Tablet | Oral | 500 mg | 2025 | |
Indications
| |||||
CARDINAL HEALTH | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
KROGER COMPANY | Tablet | Oral | 325 mg | 2024 | |
Indications
| |||||
Belmora LLC | Capsule, Liquid Filled | Oral | 325 mg | 2022 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Capsule, Liquid Filled | Oral | 325 mg | 2017 | |
Indications
| |||||
CVS PHARMACY, INC. | Capsule, Liquid Filled | Oral | 325 mg | 2016 | |
Indications
| |||||
Geri-Care Pharmaceutical Corp | Tablet | Oral | 325 mg | 1989 | |
Indications
| |||||
PuraCap Pharmaceutical LLC | Capsule, Liquid Filled | Oral | 325 mg | 2017 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Capsule, Gelatin Coated | Oral | 325 mg | 2018 | |
Indications
| |||||
Topco Associates LLC | Capsule, Liquid Filled | Oral | 325 mg | 2017 | |
Indications
| |||||
Topco Associates LLC | Capsule, Liquid Filled | Oral | 325 mg | 2016 | |
Indications
| |||||
VALU MERCHANDISERS COMPANY | Tablet | Oral | 325 mg | 2010 | |
Indications
| |||||
INGLES MARKETS, INC. | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
PuraCap Pharmaceutical LLC | Capsule, Liquid Filled | Oral | 325 mg | 2016 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Film Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Spirit Pharmaceuticals LLC | Tablet, Film Coated | Oral | 325 mg | 2023 | |
Indications
| |||||
Strategic Sourcing Services, LLC | Tablet, Film Coated | Oral | 325 mg | 2024 | |
Indications
| |||||
OPMX LLC | Tablet, Chewable | Oral | 160 mg | 2026 | |
Indications
| |||||
Rnv LLC | Liquid | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Rnv LLC | Liquid | Oral | 160 mg/5 mL | 2025 | |
Indications
| |||||
Dolgencorp, LLC | Tablet | Oral | 500 mg | 2010 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2010 | |
Indications
| |||||
Strive Pharmaceuticals Inc. | Tablet, Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Strive Pharmaceuticals Inc. | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Sato Pharmaceutical Co. , Ltd. | Tablet | Oral | 325 mg | 1996 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2020 | |
Indications
| |||||
Haleon US Holdings LLC | Tablet, Coated | Oral | 500 mg | 2022 | |
Indications
| |||||
Rugby Laboratories | Suspension | Oral | 160 mg/5 mL | 2020 | |
Indications
| |||||
Rugby Laboratories | Suspension | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
RUGBY LABORATORIES | Tablet | Oral | 325 mg | 2021 | |
Indications
| |||||
Sinew Pharma Inc. | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Sanvall Enterprises, Inc. | Liquid | Oral | 160 mg/5 mL | 2024 | |
Indications
| |||||
Safeway | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Safeway | Suspension | Oral | 160 mg/5 mL | 2018 | |
Indications
| |||||
Safeway | Tablet | Oral | 500 mg | 2015 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2015 | |
Indications
| |||||
SOHM Inc. | Tablet | Oral | 500 mg | 2013 | |
Indications
| |||||
Simpor Pharma Sdn Bhd | Tablet | Oral | 500 mg/583 mg | 2016 | |
Indications
| |||||
Sunmark | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Sunmark | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Mckesson | Tablet, Chewable | Oral | 160 mg | 2013 | |
Indications
| |||||
OPMX Chula Vista | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
OPMX Chula Vista | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Thompson |
| Oral | 500 mg | 2023 | |
Indications
| |||||
Topco Associates LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2017 | |
Indications
| |||||
Topco Associates LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2018 | |
Indications
| |||||
Topco Associates LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2018 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 1997 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 1990 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 2012 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 1993 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Topco Associates LLC | Suspension | Oral | 160 mg/5 mL | 2011 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
Topco Associates LLC | Tablet | Oral | 500 mg | 1987 | |
Indications
| |||||
Topco Associates LLC | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Topco Associates LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 | |
Indications
| |||||
Bellegrove Medical Supply, Inc. |
| Oral | 325 mg | 2014 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2018 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 325 mg | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Tablet | Oral | 325 mg | 1999 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Coated | Oral | 500 mg | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 325 mg | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 325 mg | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Coated | Oral | 500 mg | 1994 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2018 | |
Indications
| |||||
Kenvue Brands LLC | Tablet | Oral | 325 mg | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Extended Release | Oral | 650 mg | 2015 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2024 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2016 | |
Indications
| |||||
Jones Healthcare Group - Packaging Services, Inc | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2024 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2014 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Coated | Oral | 500 mg | 2021 | |
Indications
| |||||
Kenvue Brands LLC | Capsule, Liquid Filled | Oral | 500 mg | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 960 mg/30 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 1984 | |
Indications
| |||||
Kenvue Brands LLC | Powder | Oral | 500 mg/0.95 g | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Tablet, Film Coated | Oral | 500 mg | 2020 | |
Indications
| |||||
Select Corporation | Tablet, Film Coated | Oral | 500 mg | 1997 | |
Indications
| |||||
Lil' Drug Store Products, Inc. | Tablet, Coated | Oral | 500 mg | 2011 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Oral | 160 mg/5 mL | 2021 | |
Indications
| |||||
Uline | Tablet, Film Coated | Oral | 500 mg | 2019 | |
Indications
| |||||
Unishield |
| Oral | 500 mg | 2021 | |
Indications
| |||||
Target Corporation | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Target Corporation | Suspension | Oral | 160 mg/5 mL | 2009 | |
Indications
| |||||
Target Corporation | Suspension | Oral | 160 mg/5 mL | 2009 | |
Indications
| |||||
Target Corporation | Suspension | Oral | 160 mg/5 mL | 2015 | |
Indications
| |||||
Target Corporation | Tablet, Chewable | Oral | 160 mg | 2015 | |
Indications
| |||||
Target Corporation | Tablet, Chewable | Oral | 160 mg | 2015 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet | Oral | 500 mg | 2018 | |
Indications
| |||||
SPIRIT PHARMACEUTICALS LLC | Tablet | Oral | 500 mg | 2017 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Liquid | Oral | 1000 mg/30 mL | 2024 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Liquid | Oral | 1000 mg/30 mL | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Capsule, Liquid Filled | Oral | 500 mg | 2026 | |
Indications
| |||||
Pharmadel LLC | Granule, for Solution | Oral | 500 mg | 2023 | |
Indications
| |||||
WALGREENS CO. | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
WALGREENS CO. | Suspension | Oral | 160 mg/5 mL | 2023 | |
Indications
| |||||
Sixarp, LLC | Tablet | Oral | 500 mg | 2009 | |
Indications
| |||||
Aldi, Inc | Tablet | Oral | 500 mg | 2016 | |
Indications
| |||||
Selder, S. A. de C. V. | Tablet | Oral | 500 mg | 2011 | |
Indications
| |||||
Cintas Corporation | Tablet | Oral | 500 mg | 2021 | |
Indications
| |||||
Repacked & Relabeled Product Labels
The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).
Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.
Below are the non-prescription pack sizes of Pain Reliever (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Label | Forms | Routes | Acetaminophen | FDA year |
|---|---|---|---|---|
Central Texas Community Health Centers | Suppository | Rectal | 325 mg | 1992 |
A-S Medication Solutions | Tablet | Oral | 500 mg | 2018 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2009 |
A-S Medication Solutions | Liquid | Oral | 160 mg/5 mL | 2021 |
A-S Medication Solutions | Tablet | Oral | 500 mg | 2018 |
A-S Medication Solutions | Suppository | Rectal | 120 mg | 2010 |
A-S Medication Solutions | Tablet | Oral | 500 mg | 2018 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2018 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2018 |
America's Pharmacy Source LLC | Tablet | Oral | 325 mg | 2019 |
American Health Packaging | Tablet | Oral | 650 mg | 2026 |
Aphena Pharma Solutions - Tennessee, LLC | Tablet | Oral | 325 mg | 2015 |
Apotheca, Inc | Tablet | Oral | 325 mg | 1996 |
Asclemed USA, Inc. | Tablet, Extended Release | Oral | 650 mg | 2021 |
ATLANTIC BIOLOGICALS CORP | Elixir | Oral | 160 mg/5 mL | 2021 |
ATLANTIC BIOLOGICALS CORP. | Elixir | Oral | 160 mg/5 mL | 2020 |
ATLANTIC BIOLOGICALS CORP. | Elixir | Oral | 160 mg/5 mL | 2021 |
ATLANTIC BIOLOGICALS CORP. | Elixir | Oral | 160 mg/5 mL | 2020 |
ATLANTIC BIOLOGICALS CORP. | Elixir | Oral | 160 mg/5 mL | 2021 |
ATLANTIC BIOLOGICALS CORP. | Elixir | Oral | 160 mg/5 mL | 2020 |
ATLANTIC BIOLOGICALS CORP. | Elixir | Oral | 160 mg/5 mL | 2021 |
Bryant Ranch Prepack | Tablet | Oral | 500 mg | 2018 |
Bryant Ranch Prepack | Tablet, Extended Release | Oral | 650 mg | 2021 |
Bryant Ranch Prepack | Tablet | Oral | 500 mg | 2018 |
Bryant Ranch Prepack | Tablet | Oral | 325 mg | 2024 |
Bryant Ranch Prepack | Tablet | Oral | 500 mg | 2018 |
Bryant Ranch Prepack | Tablet, Extended Release | Oral | 650 mg | 2019 |
Bryant Ranch Prepack | Tablet | Oral | 500 mg | 2018 |
Central Texas Community Health Centers | Tablet, Coated | Oral | 325 mg | 2012 |
H. J. Harkins Company, Inc. | Tablet | Oral | 500 mg | 2001 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet | Oral | 0.5 g/1 g | 2020 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet, Coated | Oral | 325 mg | 2021 |
Keltman Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2011 |
Kesin Pharma Corporation | Solution | Oral | 160 mg/5 mL | 2021 |
Medsouce Pharmaceuticals | Tablet | Oral | 500 mg | 2020 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet | Oral | 500 mg | 2018 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Film Coated | Oral | 325 mg | 2025 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Film Coated | Oral | 325 mg | 2025 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet | Oral | 325 mg | 2011 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Film Coated | Oral | 500 mg | 2011 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Extended Release | Oral | 650 mg | 2022 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Extended Release | Oral | 650 mg | 2021 |
NCS HealthCare of KY, LLC dba Vangard Labs | Tablet, Film Coated | Oral | 500 mg | 2025 |
NuCare Pharmaceutiacals, Inc. | Suppository | Rectal | 120 mg | 2010 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2021 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2021 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2022 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2006 |
NuCare Pharmaceuticals, Inc. | Suppository | Rectal | 120 mg | 2010 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 1989 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2018 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2020 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2018 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2018 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2021 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2015 |
NuCare Pharmaceuticals, Inc. | Liquid | Oral | 160 mg/5 mL | 2021 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2018 |
NuCare Pharmaceuticals, Inc/ | Suspension | Oral | 160 mg/5 mL | 2018 |
PD-Rx Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2018 |
PD-Rx Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2007 |
PD-Rx Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2006 |
PD-Rx Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 2021 |
Physicians Total Care, Inc. | Tablet | Oral | 500 mg | 2002 |
Physicians Total Care, Inc. | Tablet, Chewable | Oral | 80 mg | 2006 |
Physicians Total Care, Inc. | Tablet | Oral | 500 mg | 2002 |
Physicians Total Care, Inc. | Suspension/ Drops | Oral | 80 mg/0.8 mL | 1994 |
Physicians Total Care, Inc. | Liquid | Oral | 160 mg/5 mL | 2004 |
Physicians Total Care, Inc. | Tablet | Oral | 325 mg | 2002 |
Physicians Total Care, Inc. | Suppository | Rectal | 120 mg | 2006 |
Physicians Total Care, Inc. | Suppository | Rectal | 650 mg | 2004 |
Precision Dose, Inc. | Suspension | Oral | 160 mg/5 mL | 2020 |
Precision Dose, Inc. | Suspension | Oral | 160 mg/5 mL | 2023 |
Precision Dose, Inc. | Suspension | Oral | 160 mg/5 mL | 2019 |
Precision Dose, Inc. | Suspension | Oral | 160 mg/5 mL | 2022 |
Precision Dose, Inc. | Suspension | Oral | 160 mg/5 mL | 2019 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2021 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2024 |
Preferrred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2024 |
Proficient Rx LP | Liquid | Oral | 160 mg/5 mL | 2021 |
Proficient Rx LP | Suppository | Rectal | 120 mg | 2010 |
Proficient Rx LP | Tablet | Oral | 500 mg | 2018 |
Rebel Distributors Corp | Tablet | Oral | 325–500 mg | 2007 |
Rebel Distributors Corp | Tablet, Chewable | Oral | 80 mg | 2012 |
Southern Sales & Service, Inc. | Tablet | Oral | 325 mg | 2019 |
St. Mary's Medical Park Pharmacy | Tablet | Oral | 500 mg | 2021 |
Unit Dose Services | Tablet | Oral | 325 mg | 2018 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2015 |
medsource pharmaceuticals | Tablet | Oral | 325 mg | 2015 |
Proficient Rx LP | Tablet | Oral | 325 mg | 2015 |
McKesson Corporation dba SKY Packaging | Tablet | Oral | 325 mg | 2021 |
ASCLEMED USA INC. | Tablet | Oral | 500 mg | 2015 |
Contract Pharmacy Services-PA | Tablet | Oral | 500 mg | 2006 |
Dispensing Solutions, Inc. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2002 |
ATLANTIC BIOLOGICALS CORP. | Suspension | Oral | 160 mg/5 mL | 2014 |
ATLANTIC BIOLOGICALS CORP. | Suspension | Oral | 160 mg/5 mL | 2014 |
Bryant Ranch Prepack | Suspension | Oral | 160 mg/5 mL | 2014 |
Bryant Ranch Prepack | Suspension | Oral | 160 mg/5 mL | 2014 |
Preferred Pharmaceuticals Inc. | Suspension | Oral | 160 mg/5 mL | 2023 |
Preferred Pharmaceuticals Inc. | Suspension | Oral | 160 mg/5 mL | 2023 |
Proficient Rx LP | Suspension | Oral | 160 mg/5 mL | 2014 |
Proficient Rx LP | Suspension | Oral | 160 mg/5 mL | 2014 |
Carilion Materials Management | Tablet, Chewable | Oral | 80 mg | 2011 |
A-S Medication Solutions | Tablet, Chewable | Oral | 160 mg | 2005 |
A-S Medication Solutions | Liquid | Oral | 160 mg/5 mL | 2015 |
Bryant Ranch Prepack | Tablet, Chewable | Oral | 80 mg | 2004 |
Central Texas Community Health Centers | Liquid | Oral | 160 mg/5 mL | 2015 |
Proficient Rx LP | Tablet, Chewable | Oral | 160 mg | 2005 |
ATLANTIC BIOLOGICALS CORP. | Liquid | Oral | 160 mg/5 mL | 2012 |
Atlantic Biologicals Corps | Liquid | Oral | 160 mg/5 mL | 2012 |
Atlantic Biologicals Corps | Liquid | Oral | 160 mg/5 mL | 2016 |
Atlantic Biologicals Corps | Liquid | Oral | 160 mg/5 mL | 2012 |
Allegiant Health | Tablet | Oral | 80 mg | 2015 |
A-S Medication Solutions | Liquid | Oral | 160 mg/5 mL | 1994 |
ATLANTIC BIOLOGICALS CORP. | Liquid | Oral | 160 mg/5 mL | 2021 |
Rebel Distributors Corp | Liquid | Oral | 160 mg/5 mL | 1994 |
Bryant Ranch Prepack | Tablet | Oral | 500 mg | 2018 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 500 mg | 2024 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2025 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2026 |
H. J. Harkins Company, Inc. | Tablet, Film Coated | Oral | 500 mg | 2011 |
Medsource Pharmaceuticals | Tablet | Oral | 500 mg | 2011 |
Bryant Ranch Prepack | Tablet | Oral | 500 mg | 1989 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2024 |
Preferred Pharmaceuticals Inc. | Suspension | Oral | 500 mg/15 mL | 2023 |
ST. MARY'S MEDICAL PARK PHARMACY | Tablet | Oral | 500 mg | 1989 |
St. Mary's Medical Park Pharmacy | Tablet | Oral | 500 mg | 2018 |
Bryant Ranch Prepack | Suppository | Rectal | 325 mg | 2013 |
Acme United Corporation | Tablet, Film Coated | Oral | 500 mg | 2008 |
ATLANTIC BIOLOGICALS CORP. | Suspension | Oral | 160 mg/5 mL | 2017 |
ATLANTIC BIOLOGICALS CORP. | Suspension | Oral | 160 mg/5 mL | 1998 |
ATLANTIC BIOLOGICALS CORP. | Suspension | Oral | 160 mg/5 mL | 2019 |
ATLANTIC BIOLOGICALS CORP. | Suspension | Oral | 160 mg/5 mL | 2019 |
A-S Medication Solutions | Suspension | Oral | 160 mg/5 mL | 2014 |
NuCare Pharmaceuticals, Inc. | Suspension | Oral | 160 mg/5 mL | 2014 |
Preferred Pharmaceuticals Inc. | Suspension | Oral | 160 mg/5 mL | 2023 |
Preferred Pharmaceuticals Inc. | Suspension | Oral | 160 mg/5 mL | 2023 |
Proficient Rx LP | Suspension | Oral | 160 mg/5 mL | 1993 |
Preferred Pharmaceuticals Inc. | Suspension | Oral | 160 mg/5 mL | 2024 |
A-S Medication Solutions | Tablet | Oral | 500 mg | 1989 |
ASCLEMED USA INC. | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2005 |
Bryant Ranch Prepack | Tablet, Film Coated, Extended Release | Oral | 650 mg | 2005 |
Bryant Ranch Prepack | Tablet | Oral | 325 mg | 1989 |
NuCare Pharamceuticals, Inc. | Tablet | Oral | 325 mg | 1989 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 1989 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 500 mg | 2024 |
Preferred Pharmaceuticals Inc. | Tablet | Oral | 325 mg | 2025 |
Proficient Rx LP | Tablet | Oral | 500 mg | 2022 |
Navajo Manufacturing Company Inc. | Tablet, Film Coated | Oral | 500 mg | 2016 |
Atlantic Biologicals Corps | Solution/ Drops | Oral | 80 mg/0.8 mL | 1997 |
Rebel Distributors Corp | Solution/ Drops | Oral | 80 mg/0.8 mL | 1997 |
Bryant Ranch Prepack | Liquid | Oral | 160 mg/5 mL | 2019 |
Bryant Ranch Prepack | Liquid | Oral | 160 mg/5 mL | 2024 |
Bryant Ranch Prepack | Liquid | Oral | 160 mg/5 mL | 2019 |
Bryant Ranch Prepack | Liquid | Oral | 160 mg/5 mL | 2024 |
Bryant Ranch Prepack | Liquid | Oral | 160 mg/5 mL | 2019 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2011 |
Rebel Distributors Corp | Suspension/ Drops | Oral | 80 mg/0.8 mL | 1990 |
State of Florida DOH Central Pharmacy | Capsule | Oral | 500 mg | 2013 |
Unit Dose Services | Tablet | Oral | 325 mg | 2011 |
Proficient Rx LP | Tablet, Coated | Oral | 325 mg | 2008 |
Proficient Rx LP | Tablet, Film Coated | Oral | 500 mg | 2008 |
HF Acquisition Co LLC, DBA HealthFirst | Tablet, Coated | Oral | 325 mg | 2024 |
Proficient Rx LP | Tablet, Film Coated | Oral | 500 mg | 2008 |
Allegiant Health | Tablet | Oral | 500 mg | 2014 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2007 |
A-S Medication Solutions | Tablet, Coated | Oral | 500 mg | 2018 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2007 |
ATLANTIC BIOLOGICALS CORP. | Tablet | Oral | 500 mg | 2006 |
Coupler Enterprises | Tablet | Oral | 325 mg | 2007 |
Proficient Rx LP | Tablet | Oral | 500 mg | 2006 |
Proficient Rx LP | Tablet | Oral | 500 mg | 2006 |
Unit Dose Services | Tablet | Oral | 325 mg | 2007 |
Unit Dose Services | Tablet | Oral | 325 mg | 2006 |
A-S Medication Solutions | Tablet | Oral | 500 mg | 2006 |
A-S Medication Solutions | Tablet | Oral | 500 mg | 2006 |
Denton Pharma, Inc. dba Northwind Pharmaceuticals | Tablet | Oral | 500 mg | 2020 |
REESE PHARMACEUTICAL CO. | Tablet | Oral | 650 mg | 1990 |
Chain Drug Marketing Association | Tablet | Oral | 500 mg | 2014 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 1989 |
Bryant Ranch Prepack | Tablet | Oral | 325 mg | 1989 |
Bryant Ranch Prepack | Tablet | Oral | 325 mg | 2020 |
Denton Pharma, Inc. dba Northwind Pharmaceuticals | Tablet | Oral | 325 mg | 2020 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 1989 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 1989 |
NuCare Pharmaceuticals, Inc. | Tablet | Oral | 325 mg | 1989 |
A-S Medication Solutions | Tablet | Oral | 325 mg | 2021 |
A-S Medication Solutions | Tablet, Film Coated | Oral | 500 mg | 1984 |
A-S Medication Solutions | Tablet, Film Coated | Oral | 500 mg | 2014 |
A-S Medication Solutions | Tablet, Film Coated | Oral | 500 mg | 2019 |
JC World Bell Wholesale Co. , Inc. | Tablet, Film Coated | Oral | 500 mg | 2018 |
JC World Bell Wholesale Co. , Inc. | Tablet, Film Coated | Oral | 500 mg | 2019 |
Morning Star OTC | Tablet, Film Coated | Oral | 500 mg | 1984 |
Navajo Manufacturing Company Inc. | Tablet, Film Coated | Oral | 500 mg | 2017 |
Navajo Manufacturing Company Inc. | Tablet, Film Coated | Oral | 500 mg | 2016 |
R J General Corporation | Tablet | Oral | 500 mg | 2021 |
Savings Distributors LLC | Tablet, Film Coated | Oral | 500 mg | 2019 |
America Medic | Tablet | Oral | 500 mg | 2012 |